Runxin Bio Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Runxin Bio General Information

Description

Developer of biopharmaceutical drugs intended for healthcare providers, research institutions, and regulatory bodies. The company is engaged in the research and development of proprietary anti-cancer drugs using a targeted drug discovery platform, thereby enabling the delivery of innovative, IP-protected therapies that improve treatment outcomes and expand access.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room C15-501, Bio-Nano Science Park
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room C15-501, Bio-Nano Science Park
  • Number 218 Xinghu Street
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Runxin Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Mar-2024 Completed Generating Revenue
2. Secondary Transaction - Private 09-Oct-2017 Completed Generating Revenue
1. Secondary Transaction - Private 15-May-2015 Completed Generating Revenue
To view Runxin Bio’s complete valuation and funding history, request access »

Runxin Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
CAS Investment Management Growth/Expansion Minority
YuanBio Venture Capital Venture Capital Minority
To view Runxin Bio’s complete investors history, request access »

Runxin Bio FAQs

  • When was Runxin Bio founded?

    Runxin Bio was founded in 2009.

  • Where is Runxin Bio headquartered?

    Runxin Bio is headquartered in Suzhou, China.

  • What industry is Runxin Bio in?

    Runxin Bio’s primary industry is Drug Discovery.

  • Is Runxin Bio a private or public company?

    Runxin Bio is a Private company.

  • What is Runxin Bio’s current revenue?

    The current revenue for Runxin Bio is .

  • Who are Runxin Bio’s investors?

    CAS Investment Management and YuanBio Venture Capital have invested in Runxin Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process